Company / Revenue per Share
Centessa Pharmaceuticals plc Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.10
FY2025
5-year range
$0.00 / $0.10
FY2022-FY2025
Trend
-
vs FY2024
Sector context
#132 of 154
Health Care
What the data says
Centessa Pharmaceuticals plc's revenue per share of $0.10 is lower than 86% of companies in the Health Care sector (FY2025). Improved from $0.07 to $0.10 over the past 2 years.
Based on SEC 10-K filings.
0.10 in FY2025.
Improved from $0.07 to $0.10 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 154This company $0.10 Sector average $14.98
▼
-99.3% below sector average
Key checks
Key Insights
- Ranks #132 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.07 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026